STAT

JULY 13, 2023

In a highly anticipated move, the Food and Drug Administration on Thursday approved the first over-the-counter birth control pill , a decision that could transform the way contraception is delivered in the United States. For the first time, people will now be able to readily purchase birth control online and at pharmacies, convenience stores, and grocery stores without a prescription, a requirement that has been seen as a hurdle to greater access to contraception.

Grocery Stores 246

Grocery Stores 246

Safe Biologics

JULY 13, 2023

On July 26th, ASBM and the Generics and Biosimilars Initiative (GaBI) hosted a webinar entitled MEDICARE DRUG PRICE NEGOTIATIONS: Impact on Healthcare Development and Patient Access to Medicines which focused on unintended consequences for patient access that may result from the implementation of the Inflation Reduction Act (IRA). The webinar focused on the IRA’s price negotiation provisions, which allow the Centers for Medicare and Medicaid Services to negotiate prices of certain costly drugs,

Drug Pricing 130

Drug Pricing Biosimilars Drug Development 130

STAT

JULY 13, 2023

It’s been a year since the U.S. launched its 988 national mental health hotline — and while the service is still dealing with logistical challenges , its biggest issue may be persuading more Americans to make use of it. Only 33% of Americans are at least somewhat familiar with the number and the service it provides, according to a survey of more than 2,000 adults conducted by Ipsos and the National Alliance on Mental Illness (NAMI) conducted in June 2023.

246

246

PharmaVoice

JULY 13, 2023

Besides its popularity as a weight loss drug, Ozempic and treatments like it are being investigated for Alzheimer’s, liver disease and other surprising indications.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JULY 13, 2023

By going down to the molecular level, doctors have uncovered a way to treat tumors caused by a rare brain cancer using medicines that already exist. Two cancer drugs — currently approved for the treatment of melanoma — were able to treat a rare type of brain cancer called PCP, or papillary craniopharyngioma, researchers reported in a study published Thursday in the New England Journal of Medicine.

243

243

Safe Biologics

JULY 13, 2023

REGISTER NOW: July 26th ASBM/GaBI Webinar on IRA Medicare Price Negotiation On July 26th, ASBM and the Generics and Biosimilars Initiative (GaBI) will host the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA). The webinars will focus on unintended consequences for patient access that may result from the implementation of IRA provisions.

Drug Pricing 100

Drug Pricing Biosimilars 100

Safe Biologics

JULY 13, 2023

REGISTER NOW: July 26th ASBM/GaBI Webinar on IRA Medicare Price Negotiation On July 26th, ASBM and the Generics and Biosimilars Initiative (GaBI) will host the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA). The webinars will focus on unintended consequences for patient access that may result from the implementation of IRA provisions.

Drug Pricing 100

Drug Pricing Biosimilars 100

STAT

JULY 13, 2023

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.  Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday.

237

237

Pharma Marketing Network

JULY 13, 2023

When it comes to marketing your pharma business on Facebook, you may be wondering whether you should boost a post or create an ad. Both have their own advantages and disadvantages, so it’s important to choose the right option for your needs. Boosting a post is a quick and easy way to get more exposure for your content. When you boost a post, you’re essentially paying to increase its reach and visibility.

98

98

STAT

JULY 13, 2023

In May, just before Pride Month, the Centers for Disease Control and Prevention released news worth celebrating: 2021 saw the  lowest numbers  of new HIV diagnoses in decades. New HIV infections were down 12% from 2017 to 2021, thanks to successful prevention efforts, including PrEP. The end of the epidemic may finally be in our grasp. Prevention methods now include a medication called PrEP (for pre-exposure prophylaxis), and uptake has never been higher.

234

234

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

The Pharmacist

JULY 13, 2023

The National Pharmacy Association (NPA) has released its 10-year vision for community pharmacy, setting out what the sector can do to meet NHS and patient needs over the next decade. It said that clinical services should be developed that help to cut GP waiting times, improve access to urgent care, prevent poor health, provide integrated […] The post NPA sets out 10-year vision for community pharmacy appeared first on The Pharmacist.

Community Pharmacies 93

Community Pharmacies 93

STAT

JULY 13, 2023

Health systems drowning in messages from patients are grasping for new ways to manage the deluge — including charging for especially time-consuming responses. In recent months, health systems including Cleveland Clinic and University of Washington have trotted out new billing policies for when patient portal questions require more than just a few minutes of a provider’s time — an attempt to compensate for staff time spent while also stanching the breakneck response pace pati

Hospitals 221

Hospitals 221

Pharma Marketing Network

JULY 13, 2023

The pharmaceutical industry is a highly regulated industry, and as such, marketing strategies must be carefully planned and executed. However, this does not mean that out-of-the-box marketing is not possible or effective. In fact, in some cases, out-of-the-box marketing can be the most effective way to reach target audiences and achieve marketing goals.

98

98

STAT

JULY 13, 2023

After leaving his post as the head of research at Bristol Myers Squibb, Rupert Vessey is joining venture firm Flagship Pioneering. Vessey will become an executive partner and chief scientist at Flagship starting July 31, according to a press release. He will work with the teams at Flagship that create new startups, helping them with science and R&D strategies.

216

216

Pharma Marketing Network

JULY 13, 2023

Your website is your online storefront, so it’s important to choose the best web development company to create it. In the pharmaceutical industry, where trust and credibility are essential, it’s especially important to choose a web development company that understands the specific needs of your business. Here are some factors to consider when choosing a web development company for the pharmaceutical industry: ● Experience in the pharmaceutical industry: Make sure the company you choo

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies Communication 97

STAT

JULY 13, 2023

In the 1930s, the U.S. government introduced the practice of redlining — categorizing neighborhoods based on the ethnic and racial backgrounds of the people who lived there, with areas primarily occupied by people of color identified as high-risk for mortgage lenders. The policy led to further housing segregation and decades of disinvestment in health care, schools, and other basic services and infrastructure, taking a disproportionate toll on Black communities.

216

216

The Pharmacist

JULY 13, 2023

Patients with higher prior antibiotic use are more likely to experience severe Covid-19 outcomes after infection, including hospitalisation and death, a new study led by the University of Manchester has shown. When infected with Covid-19, the chances of dying from complications due to Covid-19 is 1.34 times higher in patients with the most exposure to […] The post Frequent antibiotic use linked to severe Covid-19 side effects appeared first on The Pharmacist.

Vaccines 83

Vaccines 83

STAT

JULY 13, 2023

WASHINGTON — Congress is considering a must-pass pandemic preparedness bill that presents a good opportunity to fix the nation’s current drug shortages problem, which both parties want to do. But most indications are that lawmakers will let that opportunity pass them by. Although not new, drug shortages are now a crisis, with an increasing number of reports about cancer doctors having to ration chemotherapies and other drugs.

Chemotherapy 211

Chemotherapy 211

The Pharmacist

JULY 13, 2023

NICE appraised 70% more medicines in 2022/23 than in the year before the pandemic, its chief executive has said. It follows a new ‘proportionate approach’ to technology appraisals introduced last year to increase capacity. By simplifying, removing, or reconfiguring parts of the appraisals process NICE said it can do light-touch, faster evaluations to simpler, low-risk treatments […] The post New approval process has sped up medicines access, claims NICE appeared first on The Pharmacist.

81

81

STAT

JULY 13, 2023

WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT. The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.

Drug Pricing 209

Drug Pricing 209

Pharma Times

JULY 13, 2023

Results are from company’s phase 2 head and neck cancer trial with lead NOX inhibitor candidate - News - PharmaTimes

107

107

STAT

JULY 13, 2023

Caribou Biosciences said Thursday that its off-the-shelf CAR-T therapy induced durable, complete remissions in patients with advanced B-cell lymphoma that move it closer to the benchmarks set by more established, patient-specific CAR-T therapies. In an update to an early-stage study, 44% of the 16 patients treated with Caribou’s on-demand therapy, called CB-010, achieved a complete remission lasting a minimum of six months — a key threshold of durability.

205

205

European Pharmaceutical Review

JULY 13, 2023

In EPR’s Future of Bio/Pharmaceutical Analysis online summit last month, Lonza’s Associate Director of R&D discussed the benefits and challenges of using process analytical technology (PAT) in biologics manufacturing. The CDMO’s Carrie Mason shared that PAT, “takes a little bit more time and more effort and more capital to set up in the beginning, but once you get it up and running it’s very continuous and it should continue to provide results for a long time”.

94

94

STAT

JULY 13, 2023

Physicians are in line to absorb more Medicare cuts next year, while hospital outpatient departments and surgery centers will get billions in new revenue. The base figure that determines how much physicians get paid by Medicare will decrease by 3.3% for 2024, the federal government said Thursday. The cuts will not be distributed equally among all specialties.

Hospitals 204

Hospitals 204

BioPharma Dive

JULY 13, 2023

The oral contraceptive’s maker, Perrigo, said the pill will be available in drug and grocery stores early next year, but did not disclose its planned price.

Grocery Stores 98

Grocery Stores 98

STAT

JULY 13, 2023

For people living with multiple sclerosis, slowing or stopping this chronic and debilitating neurological disease often means sitting through hours-long infusion sessions, during which treatments slowly drip into a patient’s bloodstream. But on Thursday, Swiss pharma giant Roche raised hopes that this process could be cut down to minutes. In a clinical trial dubbed OCARINA II , the company showed that delivering Ocrevus, a treatment for certain forms of multiple sclerosis, as a 10-minute

200

200

Pharmaceutical Commerce

JULY 13, 2023

Walmart has opened 70 Specialty Pharmacies of the Community locations across the U.S. in June, and is expected to open 80 more in 11 states by the end of the year.

Specialty Pharmacies 98

Specialty Pharmacies 98

STAT

JULY 13, 2023

Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire.

182

182

European Pharmaceutical Review

JULY 13, 2023

In many European countries physicians can now prescribe medical cannabis for an array of chronic health conditions, including chronic pain, mental health disorders and neurological conditions. 1,2 Yet the pace of adoption in Europe has notably lagged countries such as Canada, Australia and the US. 1 In many countries, medical cannabis is only utilised as a therapy when licensed medications have proven ineffective. 1,2 Moreover, except for countries such as Czechia, Denmark and Germany, the cost

Compounding 87

Compounding Drug Development Clinical Pharmacology Documentation 87

STAT

JULY 13, 2023

“C ode yellow!” someone screamed. I dipped in and out of consciousness, in and out of panic.

220

220

Pharmaceutical Business Review

JULY 13, 2023

The FDA-approved oral sodium-glucose cotransporter 2 (SGLT2) inhibitor Brenzavvy is available as 20 mg tablet and is recommended once daily in the morning with or without food. It is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes. Significant reduction in haemoglobin A1c and fasting blood sugar levels were observed after 24 weeks after consumption of Brenzavvy in Phase III studies.

Diabetes 85

Diabetes 85

Drug Channels

JULY 13, 2023

Today’s guest post comes from Josh Bliss, SVP of Customer Acquisition and Head of Pharma Solutions at SingleCare Josh discusses the challenges that pharmaceutical manufacturers face connecting with consumers who could benefit from patient financial support programs. He describes SingleCare's new Pharma Solutions, which offers manufacturers the opportunity to market their copay assistance programs directly to SingleCare's millions of monthly prescription discount users.

Pharmaceutical Manufacturing 83

Pharmaceutical Manufacturing 83

Pharmaceutical Technology

JULY 13, 2023

NVIDIA signed an investment and collaboration agreement with Recursion to create AI models to accelerate drug discovery.

98

98

Express Pharma

JULY 13, 2023

MenFive is currently undergoing an additional Phase 3 study in healthy children between 9 and 15 months of age in Mali, to examine MenFive’s safety and immunogenicity when administered alongside measles/rubella and yellow fever vaccine MenFive, the first conjugate vaccine to protect against the five predominant causes of meningococcal meningitis in Africa has been prequalified by the World Health Organization (WHO).

Vaccines 78

Vaccines Immunity Immunization 78

Pharma Times

JULY 13, 2023

Facility will deliver technology to scientists, helping them to translate genomic insights - News - PharmaTimes

91

91